Early diagnosis of immune-mediated arthropathies is important for early and effective treatment, but often relies on clinical expertise. Can the use of a new genetic risk score help rule out and prioritize certain diagnoses? And does this score add any clinical utility to current clinical diagnostic pathways?
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Knevel, R. et al. Using genetics to prioritize diagnoses for rheumatology outpatients with inflammatory arthritis. Sci. Transl Med. 12, eaay1548 (2020).
Parkes, M., Cortes, A., van Heel, D. A. & Brown, M. A. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet. 14, 661–673 (2013).
Rudwaleit, M., van der Heijde, D., Khan, M. A., Braun, J. & Sieper, J. How to diagnose axial spondyloarthritis early. Ann. Rheum. Dis. 63, 535–543 (2004).
Shovman, O. et al. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis. Clin. Dev. Immunol. 12, 197–202 (2005).
Thomas, G. P. et al. Genetic diagnostic profiling in axial spondyloarthritis: a real world study. Clin. Exp. Rheumatol. 35, 229–233 (2017).
Wood, A. R. et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat. Genet. 46, 1173–1186 (2014).
Li, Z. et al. Genetic risk score prediction in ankylosing spondylitis. Arthritis Rheum. 70, 1–3553 (2018).
Stuart, P. E. et al. Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture. Am. J. Hum. Genet. 97, 816–883 (2015).
Ge, T., Chen, C. Y., Ni, Y., Feng, Y. A. & Smoller, J. W. Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat. Commun. 10, 1776 (2019).
Rostami, S. et al. Prediction of ankylosing spondylitis in the population-based HUNT study by a genetic risk score combining 110 SNPs of genome-wide significance. J. Rheumatol. 47, 204–210 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Brown, M.A., Aletaha, D. Genetic risk scores in inflammatory arthritis: a new era?. Nat Rev Rheumatol 16, 545–546 (2020). https://doi.org/10.1038/s41584-020-0473-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-020-0473-6
This article is cited by
-
HLA-B*27 and Ankylosing Spondylitis: 50 Years of Insights and Discoveries
Current Rheumatology Reports (2023)